Hochschulschrift
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
München, Ludwig-Maximilians-Universität, Diss., 2015
- Keyword
-
Reperfusion
Ischämie
Leukozytenzählung
Schaden
Todesursache
Gewebe
Permeabilität
Granulozyt
Kardiovaskuläre Krankheit
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2015
- Creator
- Contributor
-
Krombach, Fritz
- URN
-
urn:nbn:de:bvb:19-188490
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:42 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Uhl, Bernd
- Krombach, Fritz
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2015
Other Objects (12)
Urokinase-type plasminogen activator receptor in vascular calcification
Regulation of the human urokinase type plasminogen activator receptor gene
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression
The role of urokinase-type plasminogen activator (uPA) in proliferation and signal transduction within breast cancer cells
Influence of delivery on plasminogen activator inhibitor activity
Urokinase-type plasminogen activator (uPA) als Mediator der durch tissue inhibitor of metalloproteinases-1 (TIMP-1) induzierten Lebermetastasierung
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
Urokinase-type plasminogen activator receptor in vascular calcification
Regulation of the human urokinase type plasminogen activator receptor gene
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression
The role of urokinase-type plasminogen activator (uPA) in proliferation and signal transduction within breast cancer cells
Influence of delivery on plasminogen activator inhibitor activity
Urokinase-type plasminogen activator (uPA) als Mediator der durch tissue inhibitor of metalloproteinases-1 (TIMP-1) induzierten Lebermetastasierung
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
Urokinase-type plasminogen activator receptor in vascular calcification
Regulation of the human urokinase type plasminogen activator receptor gene
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression
The role of urokinase-type plasminogen activator (uPA) in proliferation and signal transduction within breast cancer cells
Influence of delivery on plasminogen activator inhibitor activity
Urokinase-type plasminogen activator (uPA) als Mediator der durch tissue inhibitor of metalloproteinases-1 (TIMP-1) induzierten Lebermetastasierung
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies